Japan Bank for International Cooperation
VC Fund
Japan Bank for International Cooperation is a VC fund focused on Energy and Manufacturing. Japan Bank for International Cooperation
- Total investments:
- 33
- Last investment:
- Lead investor:
- 48%
Last updated:
For AI agents: llms.txt
Industries Japan Bank for International Cooperation invests in
Stages Japan Bank for International Cooperation invests in
Countries Japan Bank for International Cooperation invests in
Round sizes
Round size
- Series B
- $83k–$16M
- Post-IPO Debt
- $132M–$3B
- Debt Financing
- $36M–$3B
Investment Focus
Industry
- Energy 8 (24%)
- Manufacturing 6 (18%)
- Renewable Energy 5 (15%)
- Banking 4 (12%)
- Power Grid 4 (12%)
Stage
- Debt Financing 14 (42%)
- Post-IPO Debt 8 (24%)
- Series B 4 (12%)
- Series A 3 (9%)
- Series C 1 (3%)
Country
- Japan 7 (21%)
- India 5 (15%)
- United Arab Emirates 3 (9%)
- Brazil 2 (6%)
- Canada 2 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Triorb
|
Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions. | $1.9M / Series B / Aug 07, 2026 | |
Eco-Pork
|
Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite. | Debt Financing / May 29, 2026 | |
The Brazilian Development Bank(BNDES)
|
BNDES is the main financing agent for development in Brazil | $185.1M / Debt Financing / Apr 09, 2026 | |
Nippon Steel & Sumitomo Metal
|
Nippon Steel & Sumitomo Metal Corporation Group will pursue world-leading technologies and manufacturing capabilities, and contribute to society by providing excellent products and services.1.They continue to emphasize the importance of integrity and reliability in their actions.2.They provide products and services that benefit society, andgrow in partnership with their customers.3.They pursue world-leading technologies and manufacturing capabilities.4.They continually anticipate and address future changes, innovate from within, and pursue unending progress.5.They develop and bring out the best in their people to make their Group rich with energy and enthusiasm | $5.6B / Post-IPO Debt / Mar 18, 2026 | |
Rio Tinto
|
Rio Tinto is a mining and exploration finding better ways to provide the materials the world needs. Steel is made from iron ore. Aluminum with a low carbon footprint for electric vehicles and smartphones. Copper is used in wind turbines, electric cars, and water pipes in our homes. Borates, which aid crop growth, and titanium, which is used inpaint. | $835.6M / Post-IPO Debt / Mar 10, 2026 | |
Anaut
|
Anaut specializes in software development utilizing artificial intelligence for surgical support in surgical medicine. | Series B / Mar 01, 2026 | |
Fusion Fuel Cycles
|
Fusion Fuel Cycles is a provider of fuel cycle technologies that supplies end-to-end solutions to deliver performance-driven fuel cycle. It is designed to boost fuel efficiency, reduce tritium inventory, and maximise heat transfer for power conversion to enable cost-effective fusion energy systems. It is a joint venture between Canadian NuclearLaboratories (CNL) and Kyoto Fusioneering (KF). | $14.5M / Debt Financing / Sep 18, 2025 | |
Kyoto Fusioneering
|
Kyoto Fusioneering is a research & development, design, and manufacture of parts related to fusion reactors. | $36M / Debt Financing / Sep 09, 2025 | |
Metagen Therapeutics
|
Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. | $15.7M / Series B / Sep 08, 2025 | |
|
Metagen Therapeutics
|
Metagen Therapeutics (MGTx) is a clinical-stage company operating Japan’s first GMP-compliant manufacturing platform for fecal microbiota transplantation (FMT) therapies. The company combines proprietary paired metagenomic datasets with AI/ML-driven donor-recipient matching to advance precision microbiome medicine across ulcerative colitis,immuno-oncology, and neurodegenerative disease. Headquartered in Tsuruoka, Japan, MGTx leverages a cross-border regulatory strategy spanning PMDA and FDA pathways, positioning it as a platform bridging Japanese clinical innovation with global market access. | $15.7M / Series B / Sep 08, 2025 | |
| See all 33 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Japan Bank for International Cooperation invest in?
Japan Bank for International Cooperation invests primarily in Energy, Manufacturing and Renewable Energy startups, most often at Debt Financing and Post-IPO Debt stage. Most of the 33 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Japan Bank for International Cooperation's check size?
Japan Bank for International Cooperation typically joins rounds of $83k–$16M at Series B, $132M–$3B at Post-IPO Debt and $36M–$3B at Debt Financing. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Japan Bank for International Cooperation participates in.
When did Japan Bank for International Cooperation last invest?
The most recent investment recorded for Japan Bank for International Cooperation closed in Aug 2026. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
